The roles of cancer stem cells and therapeutic implications in melanoma
Authors:
Open Access
- 14 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1486680
Abstract
Melanoma is a highly malignant skin tumor characterized by high metastasis and poor prognosis. Recent studies have highlighted the pivotal role of melanoma stem cells (MSCs)—a subpopulation of cancer stem cells (CSCs)—in driving tumor growth, metastasis, therapeutic resistance, and recurrence. Similar to CSCs in other cancers, MSCs possess unique characteristics, including specific surface markers, dysregulated signaling pathways, and the ability to thrive within complex tumor microenvironment (TME). This review explored the current landscape of MSC research, discussing the identification of MSC-specific surface markers, the role of key signaling pathways such as Wnt/β-catenin, Notch, and Hedgehog (Hh), and how interactions within the TME, including hypoxia and immune cells, contribute to MSC-mediated drug resistance and metastatic behavior. Furthermore, we also investigated the latest therapeutic strategies targeting MSCs, such as small-molecule inhibitors, immune-based approaches, and novel vaccine developments, with an emphasis on their potential to overcome melanoma progression and improve clinical outcomes. This review aims to provide valuable insights into the complex roles of MSCs in melanoma biology and offers perspectives for future research and therapeutic advances against this challenging disease.Keywords
This publication has 185 references indexed in Scilit:
- The Role of Nerve Fibers in the Tumor Immune Microenvironment of Solid TumorsAdvanced Biology, 2022
- Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy responseJournal of Leukocyte Biology, 2020
- S1P Signaling in the Tumor Microenvironment2020
- Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down‐regulating PI3K/AKT pathwayCancer Medicine, 2019
- Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsStem Cells, 2016
- Dedifferentiation and reprogramming: origins of cancer stem cellsEMBO Reports, 2014
- CD44 Expressed on Cancer-Associated Fibroblasts Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor MicroenvironmentStem Cells, 2013
- ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic TargetsStem Cells, 2012
- HEDGEHOG-GLI Signaling Drives Self-Renewal and Tumorigenicity of Human Melanoma-Initiating CellsStem Cells, 2012
- High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor CellsStem Cells, 2009